ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 655509 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 655509; 2) Community: the network communities that were significantly associated with the response to NSC 655509; 3) Molecule: the relationships between components within communities and NSC 655509; 4) MDR: the compounds that were significantly associated with the NSC 655509.

NSC Compound Enrichment Correlation
NSC 661205 Null 0.012942183459279 0.47931203
NSC 664890 Null 0.012942183459279 0.060388462
NSC 667909 Null 0.012942183459279 0.26451945
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.012942183459279 0.32219721
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.012942183459279 0.3401602
NSC 726217 Combretastatin A4-analogue 0.012942183459279 0.47095604
NSC 735472 (2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol 0.012942183459279 0.3118421
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.012942183459279 0.18997403
NSC 749169 8H-thieno[2'3':4,5]pyrimido[2,1-a]phthalazin-8-one,5-[[3-(dimethylamino)propyl]amino]-9,10-dimethyl 0.012942183459279 0.27620707
NSC 762346 Null 0.012942183459279 0.31303545
Total:54  Current:15    [First] [Prev] [Next] [Last]